The anticancer role of ADIPOQ was mainly induced by its receptors, which have been demonstrated to repress colon cancer cell lines (including HCT116, HT29 and LoVo) proliferation via ADIPOR1- and -R2-mediated 5′-AMP -activated protein kinase (AMPK). This evidence concerns the gene ADIPOQ and colonic neoplasm.